03 November 2020
: Case report 
Efficacy of Hyperthermia in Treatment of Recurrent Metastatic Breast Cancer After Long-Term Chemotherapy: A Report of 2 Cases
Unusual clinical course, Unusual setting of medical care
Hirozumi Sawai1ABCDEF*, Masaaki Kurimoto1ABCD, Yuka Suzuki2BCD, Yoshimi Yamaguchi2BCD, Akemi Murata2BCD, Enami Suganuma2BCD, Kazuya Yamamoto2ABCD, Hiromasa Kuzuya1BCDF, Shuhei Ueno1BCDF, Shuji Koide1ABCF, Hajime Koide1BCDF, Atsushi Kamiya1ABCEDOI: 10.12659/AJCR.926647
Am J Case Rep 2020; 21:e926647
Figure 1. Detailed clinical history and notable trend of tumor markers since October 2018 in Case 1. AI – aromatase inhibitor; EC – epirubicin hydrochloride+cyclophosphamide hydrate; EM – eribulin mesylate; MA – medroxyprogesterone acetate; Rad – radiation therapy; RF-HT – radiofrequency hyperthermia; TAM – tamoxifen; TC – docetaxel hydrate+cyclophosphamide hydrate; CEA – carcinoembryonic antigen (<5.0 ng/mL); CA15-3 – cancer antigen 15-3 (<25 U/mL).